Investment Criteria   Investment Focus Nexus invests in medical technology companies and in life science companies in various stages of development, including medical devices, diagnostics, biotechnology, specialty pharmaceutical and drug discovery tools. We prefer to lead our investments and to work in a hands-on manner with our portfolio companies, committing multiple partners to each investment.   Management/Entrepreneurs We believe that the strength and background experience of the management team will almost always define a company's opportunity for success. We look for proven management teams that are passionately driven to succeed.   Value-Added Investors We pride ourselves in being a value-added investor by staying actively involved with our portfolio companies. We will work closely with portfolio companies to identify and attract executive talent, board members, advisors, and consultants. Additionally, we can assist in devising market strategy, entrepreneurial management, and business development. We have a history of helping our companies expand their network with introductions to institutional fundraising sources, marketing and development partners, and strategic customers.   Investment Assessment Our detailed assessment of investment candidates includes the evaluation of many profiles, including: The company's products and technologies and their market opportunity; Intellectual property, legal issues, regulatory status and remaining pathway; Risk factors and means of overcoming risks; Future requirements for human and financial resources; Opportunities for adding value, including synergistic M&A opportunities; Exit strategy and timetable for achieving liquidity. Submission of Business Plans   We invite the submission of executive summaries and business plans for review. Materials may be sent to . While we observe a policy of confidentiality regarding such materials, submissions should not be construed as our having signed a confidentiality agreement. We look forward to reviewing appropriate opportunities with you.